Safety of antifibrinolytics in 6583 pediatric patients having craniosynostosis surgery: A decade of data reported from the multicenter Pediatric Craniofacial Collaborative Group
Pediatric Anesthesia2022Vol. 32(12), pp. 1339–1346
Citations Over TimeTop 10% of 2022 papers
Michael R. King, Steven J. Staffa, Paul A. Stricker, Carolina Pérez‐Pradilla, Olivia Nelson, Hubert A. Benzon, Susan M. Goobie, the Pediatric Craniofacial Collaborative Group
Abstract
This multicenter international experience of pediatric craniofacial surgery reports no increase in seizures or thromboembolic events in those that received antifibrinolytics (tranexamic acid and epsilon-aminocaproic acid) versus those that did not. This report provides further evidence of antifibrinolytic safety. We recommend following pharmacokinetic-based dosing guidelines for administration.
Related Papers
- → Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery?(2006)342 cited
- → The Relative Efficacy of Antifibrinolytics in Adolescent Idiopathic Scoliosis(2014)120 cited
- → Use of Topical Tranexamic Acid or Aminocaproic Acid to Prevent Bleeding After Major Surgical Procedures(2011)78 cited
- → Efectividad de ácido tranexámico en prótesis total de rodilla en la práctica clínica habitual(2008)12 cited
- → Застосування антифібринолітичної терапії у періопераційному періоді у дітей та дорослих(2023)